Patents Assigned to DEERLAND ENZYMES, INC.
-
Patent number: 12194142Abstract: The present invention relates to methods of treating gastrointestinal irregularity, as well as promoting, maintaining, and restoring gastrointestinal regularity, and maintaining healthy gut microflora in an individual. The present invention relates to methods comprising orally administering to an individual a Bacillus subtilis composition wherein the individual's gastrointestinal irregularity is treated, and/or the individual's gastrointestinal regularity and/or healthy gut microflora is promoted, maintained, and/or restored.Type: GrantFiled: June 21, 2021Date of Patent: January 14, 2025Assignee: Deerland Enzymes, Inc.Inventors: John Deaton, Ana Maria Cuentas
-
PROBIOTIC (BACILLUS SUBTILIS) SUPPLEMENTATION FOR IMPROVEMENT OF BODY COMPOSITION IN FEMALE ATHLETES
Publication number: 20240325465Abstract: The present invention relates to methods of improving body composition and reducing body fat percentage in an individual. The present invention relates to methods comprising administering to an individual a Bacillus subtilis composition wherein the individual's body fat percentage is reduced.Type: ApplicationFiled: June 6, 2024Publication date: October 3, 2024Applicant: Deerland Enzymes, Inc.Inventors: John Deaton, Ana Maria Cuentas -
Patent number: 12005087Abstract: The present invention relates to methods of improving body composition and reducing body fat percentage in an individual. The present invention relates to methods comprising administering to an individual a Bacillus subtilis composition wherein the individual's body fat percentage is reduced.Type: GrantFiled: June 22, 2021Date of Patent: June 11, 2024Assignee: Deerland Enzymes, Inc.Inventors: John Deaton, Ana Maria Cuentas
-
Publication number: 20240075078Abstract: Methods of using Bacillus subtilis probiotic supplementation to promote lower circulating TNF-? in resistance trained males are presented. Methods of administering Bacillus subtilis probiotic supplementation to an athletic population in conjunction with a sound nutrition and training regimen are presented herein. College athletes typically undergo periods of elevated stress both physically and mentally which may negatively affect recovery and adaptation. 12-weeks of probiotic supplementation resulted in attenuated circulating TNF-? concentrations in college athletes following offseason training.Type: ApplicationFiled: November 14, 2023Publication date: March 7, 2024Applicant: Deerland Enzymes, Inc.Inventors: John Deaton, Ana Maria Cuentas
-
Patent number: 11813296Abstract: Methods of using Bacillus subtilis probiotic supplementation to promote lower circulating TNF-? in resistance trained males are presented. Methods of administering Bacillus subtilis probiotic supplementation to an athletic population in conjunction with a sound nutrition and training regimen are presented herein. College athletes typically undergo periods of elevated stress both physically and mentally which may negatively affect recovery and adaptation. 12-weeks of probiotic supplementation resulted in attenuated circulating TNF-? concentrations in college athletes following offseason training.Type: GrantFiled: October 4, 2019Date of Patent: November 14, 2023Assignee: Deerland Enzymes, Inc.Inventors: John Deaton, Ana Maria Cuentas
-
Publication number: 20230116978Abstract: This disclosure relates to an enzymatic method including the steps of adding water to a reactor vessel with gentle mixing and minimal heating, adding osmotic protectant solution, adding plant material to the reactor, adding cell wall degrading enzymes at 0.1% wt/wt based on plant weight, heating the reactor now filled with plant material, osmotic protectant solution and enzyme blend solution to 30° C.-35° C., adding the enzyme mixture to the reactor and starting the timer for up to 2 hours, adding bulk density enhancer, further mixing the product, and drying the finished product containing protoplasts. The protoplast containing product may be provided in a dietary supplement for human use having antioxidant and anti-inflammatory properties.Type: ApplicationFiled: October 14, 2022Publication date: April 20, 2023Applicant: Deerland Enzymes, Inc.Inventor: John Deaton
-
Patent number: 11160838Abstract: Methods of treating, removing, or preventing the accumulation of bacteria, fungus, and/or yeast on a surface, and/or treating or preventing fungal, bacterial, and/or yeast infections in a mammal, with compositions containing Bacillus subtilis or material secreted from Bacillus subtilis are provided. Compositions including Bacillus subitlis or material secreted from Bacillus subtilis that can be used in methods of treating, removing, or preventing the accumulation, growth, or activity of bacteria, fungus, and/or yeast on a surface, and/or treating or preventing fungal, bacterial, and/or yeast infections in a mammal, are provided.Type: GrantFiled: August 10, 2020Date of Patent: November 2, 2021Assignee: Deerland Enzymes, Inc.Inventors: John Deaton, Ana Maria Cuentas
-
Publication number: 20210315808Abstract: The present invention relates to methods of treating gastrointestinal irregularity, as well as promoting, maintaining, and restoring gastrointestinal regularity, and maintaining healthy gut microflora in an individual. The present invention relates to methods comprising orally administering to an individual a Bacillus subtilis composition wherein the individual's gastrointestinal irregularity is treated, and/or the individual's gastrointestinal regularity and/or healthy gut microflora is promoted, maintained, and/or restored.Type: ApplicationFiled: June 21, 2021Publication date: October 14, 2021Applicant: Deerland Enzymes, Inc.Inventors: John Deaton, Ana Maria Cuentas
-
PROBIOTIC (BACILLUS SUBTILIS) SUPPLEMENTATION FOR IMPROVEMENT OF BODY COMPOSITION IN FEMALE ATHLETES
Publication number: 20210315945Abstract: The present invention relates to methods of improving body composition and reducing body fat percentage in an individual. The present invention relates to methods comprising administering to an individual a Bacillus subtilis composition wherein the individual's body fat percentage is reduced.Type: ApplicationFiled: June 22, 2021Publication date: October 14, 2021Applicant: Deerland Enzymes, Inc.Inventors: John Deaton, Ana Maria Cuentas -
Publication number: 20210145899Abstract: Methods of treating, removing, or preventing the accumulation of bacteria, fungus, and/or yeast on a surface, and/or treating or preventing fungal, bacterial, and/or yeast infections in a mammal, with compositions containing Bacillus subtilis or material secreted from Bacillus subtilis are provided. Compositions including Bacillus subitlis or material secreted from Bacillus subtilis that can be used in methods of treating, removing, or preventing the accumulation, growth, or activity of bacteria, fungus, and/or yeast on a surface, and/or treating or preventing fungal, bacterial, and/or yeast infections in a mammal, are provided.Type: ApplicationFiled: August 10, 2020Publication date: May 20, 2021Applicant: Deerland Enzymes, Inc.Inventors: John Deaton, Ana Maria Cuentas
-
Publication number: 20200108106Abstract: Methods of using Bacillus Subtilis probiotic supplementation to promote lower circulating TNF-? in resistance trained males are presented. Methods of administering Bacillus Subtilis probiotic supplementation to an athletic population in conjunction with a sound nutrition and training regimen are presented herein. College athletes typically undergo periods of elevated stress both physically and mentally which may negatively affect recovery and adaptation. 12-weeks of probiotic supplementation resulted in attenuated circulating TNF-? concentrations in college athletes following offseason training.Type: ApplicationFiled: October 4, 2019Publication date: April 9, 2020Applicant: Deerland Enzymes, Inc.Inventors: John Deaton, Ana Maria Cuentas
-
Publication number: 20190255122Abstract: This disclosure provides a method of treating gastrointestinal inflammation such as inflammatory bowel disease (IBS) with a bacteriophage containing composition. The bacteriophage containing composition can be used as prebiotic supplementation and support of the gastrointestinal microflora. This disclosure relates to compositions that comprise one or more types of bacteriophage and methods of using such bacteriophages as a prebiotic to promote the growth of beneficial bacteria by decreasing harmful bacterial populations and releasing nutrients into the environment for good bacteria in the digestive system of an individual.Type: ApplicationFiled: September 25, 2018Publication date: August 22, 2019Applicant: Deerland Enzymes, Inc.Inventors: John Deaton, Ana Maria Cuentas
-
Publication number: 20190125810Abstract: The present invention relates to methods of treating gastrointestinal irregularity, as well as promoting, maintaining, and restoring gastrointestinal regularity, and maintaining healthy gut microflora in an individual. The present invention relates to methods comprising orally administering to an individual a Bacillus subtilis composition wherein the individual's gastrointestinal irregularity is treated, and/or the individual's gastrointestinal regularity and/or healthy gut microflora is promoted, maintained, and/or restored.Type: ApplicationFiled: September 25, 2018Publication date: May 2, 2019Applicant: Deerland Enzymes, Inc.Inventors: John Deaton, Ana Maria Cuentas
-
PROBIOTIC (BACILLUS SUBTILIS) SUPPLEMENTATION FOR IMPROVEMENT OF BODY COMPOSITION IN FEMALE ATHLETES
Publication number: 20190125811Abstract: The present invention relates to methods of improving body composition and reducing body fat percentage in an individual. The present invention relates to methods comprising administering to an individual a Bacillus subtilis composition wherein the individual's body fat percentage is reduced.Type: ApplicationFiled: September 25, 2018Publication date: May 2, 2019Applicant: Deerland Enzymes, Inc.Inventors: John Deaton, Ana Maria Cuentas -
Patent number: 9839657Abstract: Disclosed herein are compositions that comprise one or more types of bacteriophage and methods of using such bacteriophages as a prebiotic to promote the growth of beneficial bacteria by decreasing harmful bacterial populations and releasing nutrients into the environment for good bacteria in the digestive system of an individual.Type: GrantFiled: March 8, 2013Date of Patent: December 12, 2017Assignee: DEERLAND ENZYMES, INC.Inventors: John Deaton, Elizabeth Ertle, Hilton Grant Dawson
-
Publication number: 20130101634Abstract: An antimicrobial composition for reducing bacterial overgrowth in the small intestine is disclosed. The composition comprises a lytic enzyme combined with one or more anti-microbial essential oils, and a probiotic. Unlike broad spectrum antibiotics the disclosed composition does not enter the blood stream, does not destroy all intestinal microflora, and can be used on a continuing basis.Type: ApplicationFiled: October 12, 2012Publication date: April 25, 2013Applicant: DEERLAND ENZYMES, INC.Inventor: Deerland Enzymes, Inc.